References - CLS

Start Pipeline References

References

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU.Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting. Eur Urol. 2015 Apr;67(4):771-777.

Fujihara A, Ukimura O.Focal therapy of localized prostate cancer. Int J Urol. 2022 Nov;29(11):1254-1263.

Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, McCluskey S, Konukhova A, Hlasny E, van der Kwast TH, Incze PF, Zlotta AR, Hamilton RJ, Haider MA, Kucharczyk W, Perlis N.MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 2021 Mar;298(3):695-703.

Heard JR, Naser-Tavakolian A, Nazmifar M, Ahdoot M.Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. Prostate Cancer Prostatic Dis. 2022 Mar 4.

Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, Fütterer JJ, Rovers MM.An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. 2022 Jan;81(1):5-33.

Kayano PP, Klotz L.Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Curr Opin Urol. 2021 Jan;31(1):49-57.

Lee T, Mendhiratta N, Sperling D, Lepor H.Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. Rev Urol. 2014;16(2):55-66.

Walser EM, Sze TF, Ross JR, Karamanian AA, Woodrum DAMRI-Guided Prostate Interventions. AJR Am J Roentgenol. 2016 Oct;207(4):755-763. doi: 10.2214/AJR.16.16663.

Eric Walser, Anne Nance, Leslie Ynalvez, Shan Yong, Jacqueline S. Aoughsten, Eduardo J. Eyzaguirre, Stephen B. Williams, Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease, Journal of Vascular and Interventional Radiology

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region

Global

US